Chloramphenicol, dexamethasone, tetrahydrozoline (Spersadexoline)
Chloramphenicol, dexamethasone, tetrahydrozoline
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Spersadexoline EACH 100 ml CONTAINS CHLORAMPHENICOL A 0,5 g DEXAMETHASONE SODIUM PHOSPHATE A 0,1 g TETRAHYDROZOLINE HYDROCHLORIDE A 0,025 g | Not listed | H1287 | Old Medicine | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Chloramphenicol
Consolidated Schedules 06 July 2026, line 5787
S4: Dexamethasone
Consolidated Schedules 06 July 2026, line 6001
S3: Sodium phosphate
- in preparations intended for the management of faecal impaction or for bowel cleansing prior to surgical and diagnostic procedures. (S0)
Consolidated Schedules 06 July 2026, lines 4251 to 4252
S2: Tetrahydrozoline
- except when intended for nasal use.
Consolidated Schedules 06 July 2026, line 2717
S1: Tetrahydrozoline
- when intended for nasal use.
Consolidated Schedules 06 July 2026, line 1106
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.